Coronavirus Disease 2019 Severity in Obese Patients May Be Linked to Viral Load and Immune Response

Affiliations

Editorial

Alexander M Lewis et al. J Infect Dis. 2021.

. 2021 Nov 16;224(9):1449-1451.

doi: 10.1093/infdis/jiab397.

¹ Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri, USA.

No abstract available

Comment on

Clinical, Immunological, and Virological SARS-CoV-2 Phenotypes in Obese and Nonobese Military Health System Beneficiaries.
Epsi NJ, Richard SA, Laing ED, Fries AC, Millar E, Simons MP, English C, Colombo CJ, Colombo RE, Lindholm DA, Ganesan A, Maves RC, Huprikar N, Larson D, Mende K, Chi SW, Madar C, Lalani T, Broder CC, Tribble D, Agan BK, Burgess TH, Pollett SD; EPICC COVID-19 Cohort Study Group. Epsi NJ, et al. J Infect Dis. 2021 Nov 16;224(9):1462-1472. doi: 10.1093/infdis/jiab396. J Infect Dis. 2021. PMID: 34331541 Free PMC article.

1. Noor FM, Islam MM. Prevalence and associated risk factors of mortality among COVID-19 patients: a meta-analysis. J Community Health 2020; 45:1270–82. - PMC - PubMed
1. Czernichow S, Beeker N, Rives-Lange C, et al. ; AP-HP/Universities/INSERM COVID-19 Research Collaboration and AP-HP COVID CDR Initiative. Obesity doubles mortality in patients hospitalized for severe acute respiratory syndrome coronavirus 2 in Paris hospitals, France: a cohort study on 5,795 patients. Obesity (Silver Spring) 2020; 28:2282–9. - PMC - PubMed
1. Zhang XY, et al. . A systematic review and meta-analysis of obesity and COVID-19 outcomes. Scientific Reports 2021; 11:7193. - PMC - PubMed
1. Epsi N, Richard SA, Laing ED, et al. . Clinical, immunological and virological SARS-CoV-2 phenotypes in obese and non-obese military health system beneficiaries. J Infect Dis 2021; 224:1462–72. - PMC - PubMed
1. Legros V, Denolly S, Vogrig M, et al. . A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity. Cell Mol Immunol 2021; 18:318–27. - PMC - PubMed